Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 25 of 25 for:    ASP 2215 OR Gilteritinib

Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03680677
Recruitment Status : Recruiting
First Posted : September 21, 2018
Last Update Posted : May 30, 2019
Sponsor:
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2023
Estimated Study Completion Date : November 2025